2026 RNDS | Diagnostic Workup Masterclass: Medical Professionals Share Insight on Tests and Criteria @wearesrna
2026 RNDS | Diagnostic Workup Masterclass: Medical Professionals Share Insight on Tests and Criteria  @wearesrna
Uploaded October 2026 | Updated November 2026, 3 hours ago
In this session from the 2026 Rare Neuroimmune Disorders Symposium (RNDS), Benjamin Greenberg, MD, MHS, of the University of Texas Southwestern, Carlos A. Pardo, MD, of Johns Hopkins University, and Shuvro Roy, MD, of the University of Washington discussed how diagnosis of rare neuroimmune disorders has changed over 25 years [00:01:25]. Dr. Pardo described how registries and stored blood and spinal fluid samples led to the discovery of the aquaporin-4 and MOG antibodies, and why listening to the person in front of you still matters [00:02:49]. Dr. Greenberg explained how clinicians learn to recognize new conditions, using acute flaccid myelitis as an example, and Dr. Roy described how understanding of MOG antibody disease (MOGAD) has evolved, including the 2023 diagnostic criteria and the gray areas that remain [00:08:39]. The panel explained why antibody tests differ between labs, why timing and levels matter, and why a test result is not a diagnosis by itself [00:15:50]. They also cautioned about direct-to-consumer testing panels [00:25:57].

Benjamin Greenberg, MD, MHS, directs the Transverse Myelitis and Neuromyelitis Optica Program at the University of Texas Southwestern Medical Center and is recognized internationally as an expert in rare autoimmune disorders of the central nervous system. His research focuses on better ways to diagnose and treat these disorders, including biomarkers that may help distinguish between neurologic conditions.

Carlos A. Pardo, MD, is a Professor of Neurology and Pathology in the Division of Neuroimmunology and Neuroinfectious Disorders at Johns Hopkins University School of Medicine and Director of the Johns Hopkins Myelitis and Myelopathy Center in Baltimore, Maryland. He is the principal investigator of the Neuroimmunopathology Laboratory and a clinical neurologist at the Multiple Sclerosis and Transverse Myelitis Centers at Johns Hopkins Hospital. His clinical specialization is neuroimmunological and infectious disorders of the nervous system, with particular focus on multiple sclerosis, transverse myelitis, neurosarcoidosis, and neurological complications of autoimmune disorders.

Shuvro Roy, MD, is an Assistant Professor of Neurology at the University of Washington, specializing in neuroimmunology, with a focus on multiple sclerosis and related neuroimmunologic disorders. He is Co-Director of the UW SRNA Center of Excellence for Rare Neuroimmune Disorders. Dr. Roy is engaged in projects aimed at improving access to care, addressing healthcare disparities, and enhancing patient safety for people living with MS and related conditions.

00:00 Welcome and Introductions
01:25 How Diagnosis Has Changed
02:49 Registries, Samples and Listening
08:39 Recognizing New Conditions
11:26 Learning About MOGAD
15:50 Why Antibody Tests Differ
21:14 A Test Result Is Not a Diagnosis
25:57 Direct-to-Consumer Testing
29:45 Putting the Pieces Together
2026 RNDS | Diagnostic Workup Masterclass: Medical Professionals Share Insight on Tests and Criteria2024 RNDS | What’s my Diagnosis? Community Members Share their Diagnostic JourneyAsk the Expert 1403. Open Q&A on MOG Antibody Disease (MOGAD)2025 RNDS en Español | Trastornos neuroinmunes poco frecuentes: EMAD y MFA2023 RNDS | Open Q&A SessionCommunity Meets Clinic 305. Dr. Elena GrebenciucovaCommunity Meets Clinic 307. Dr. Melissa WrightShaping the Future of Rare Neuroimmune Disorders: The Exponential Impact of the Lubin Fellowship2023 RNDS en Español | ¿Qué son los trastornos en el espectro de neuromielitis óptica (NMOSD)?2026 RNDS | How to Get Involved in Research2026 RNDS | Pediatric Symptom Toolkit: Fatigue, Pain, Mobility, and Bladder/Bowel Routines2024 NMOSD Together | Community Q&A
SRNA |

2026 RNDS | Diagnostic Workup Masterclass: Medical Professionals Share Insight on Tests and Criteria

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER